Long-term transgene expression in fetal rat suprachiasmatic nucleus neurografts following ex vivo adenoviral vector-mediated gene transfer

Experimental Neurology

Volumn 145, Issue 2 I, 1997, Pages 536-545

  Boer, G J ^a   Van Esseveldt, K E ^a   Hermens, W T J M C ^a   Liu, R ^a   Verhaagen, J ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; NEUROTROPHIC FACTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN THIRD VENTRICLE; CLONING VECTOR; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EMBRYO; EXPLANT; FEMALE; FETUS; GENE EXPRESSION; GENE TRANSFER; GRAFT SURVIVAL; MACROPHAGE; MALE; NERVE CELL NECROSIS; NERVE FIBER GROWTH; NERVE GRAFT; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; SUPRACHIASMATIC NUCLEUS; TRANSGENE;

EID: 0030835493     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6489     Document Type: Article

References (46)

1. Akalan, N., and M. S. Grady. 1994. Angiogenesis and the blood-brain barrier in intracerebral solid and cell suspension grafts. Surg. Neurol. 42: 517-522.
2. Akli, S., C. Caillaud, E. Vigne, L. D. Stratford-Perricaudet, L. Poenaru, M. Perricaudet, A. Kahn, and M. R. Peschanski. 1993. Transfer of a foreign gene into the brain using adenovirus vecors. Nature Genet. 3: 224-228.
3. Bina, K. G., and B. Rusak. 1996. Nerve growth factor phase shifts circadian activity rhythms in Syrian hamsters. Neurosci. Lett. 206: 97-100.
4. Boer, G. J. 1996. Neurotransplantation of the biological clock in mammals, importance and perspectives. Biol. Rhythm Res., in press.
5. Boer, G. J., and H. A. Griffioen. 1990. Developmental and functional aspects of grafting of the suprachiasmatic nucleus in the Brattleboro and arhythmic rat. Eur. J. Morphol. 28: 330-345.
6. Boer, G. J., H. A. Griffioen, and P. Saeed. 1992. Grafted fetal suprachiasmatic nucleus cells survive much better in tissue pieces than in suspension. Restorative Neurol. Neurosci. 4: 261-269.
7. Boer, G. J., H. A. Griffioen, H. Duindam, T. P. Van der Woude, and W. J. Rietveld. 1993. Light/dark-induced effects on behavioral rhythms in suprachiasmatic nucleus lesioned rats irrespective of the presence of functional suprachiasmatic nucleus brain implants. J. interdiscipl. Cycle Res. 24: 118-136.
8. Boer, G. J., A. A. Kelleman, R. E. Baker, P. Te Riele, M. G. P. Feenstra, M. Botterblom, and B. H. W. Erdtsieck-Ernste. 1995. Development and isoproterenol-induced regulation of adrenoceptor binding in cultured rat neonatal explants is seen only with the beta-1, not with the beta-2 subtype. Neurochem. Res. 20: 579-586.
9. Boer, G. J., K. E. Van Esseveldt, W. T. J. M. C. Hermens and J. Verhaagen. 1996. Sustained expression of ex vivo adenoviral vector-delivered LacZ reporter gene in the suprachiasmatic nucleus transplantation model. Cell Transplant., in press.
10. Byrnes, A. P., J. E. Rusby, M. J. A. Wood, and H. M. Charlton. 1995. Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66: 1015-1024.
11. Byrnes, A. P., R. E. MacLaren, and H. M. Charlton. 1996. Immunological instability of persistent adenovirus vectors leads to renewed inflammation, reduced gene expression, and demyelination. J. Neurosci. 16: 3045-3055.
12. Caillaud, C., S. Akli, E. Vigne, A. Koulakoff, M. Perricaudet, L. Poenaru, A. Kahn, and Y. Berwald-Netter. 1993. Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells. Eur. J. Neurosci. 5: 1287-1291.
13. Davidson, B. L., E. D. Allen, K. F. Kozarsky, J. M. Wilson, and B. J. Roessler. 1993. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3: 219-223.
14. Ernfors, P., T. Ebendal, J. Olson, P. Mouton, I. Strömberg, H. Persson. 1989. A cell line producin recombinant nerve growth factor evokes growth responses in intrinsic and grafted central cholinergic neurons. Proc. Natl. Acad. Sci. USA 86: 4756-4760.
15. Fallaux, F. J., O. Kranenburg, S. J. Cramer, A. Houweling, H. Van Ormondt, R. C. Hoeben, and A. J. Van der Eb. 1996. Characterization of 911: A new helper cell line for the titration and propagation of early-region-1-deleted adenoviral vectors. Hum. Gene Ther. 7: 215-222.
16. Förander, P., S. Söderström, C. Humpel, and I. Strömberg. 1996. Chronic infusion of nerve growth factor increases cholinergic markers and inhibits striatal neuronal discharge rate. Eur. J. Neurosci., 8: 1822-1832.
17. Frim, D. M., T. A. Uhler, W. R. Galpern, M. F. Beal, X. O. Breakefield, and O. Isacson. 1994. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in rat. Proc. Natl. Acad. Sci. USA 91: 5104-5108.
18. Graham, F. L., and L. Prevec. 1991. Manipulation of adenovirus vectors. Methods Mol. Biol. 7: 109-128.
19. Griffioen, H. A., E. Van der Beek, and G. J. Boer. 1992. Gelatin embedding to preserve lesion-damaged hypothalami and intracerebroventricular grafts for vibratome slicing and immunocytochemistry. J. Neurosci. Meth. 43: 43-47.
20. Griffioen, H. A., H. Duindam, T. P. Van der Woude, W. J. Rietveld, and G. J. Boer. 1993. Functional development of fetal suprachiasmatic nucleus grafts in suprachiasmatic nucleus-lesioned rats. Brain Res. Bull. 31: 145-160.
21. Gundersen, H. J. G., and E. B. Jensen. 1987. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147: 229-263.
22. Hermens, W. T. J. M. C., R. J. Giger, A. J. G. D. Holtmaat, P. A. Dijkhuizen, D. A. Houweling, and J. Verhaagen. 1997. Transient gene transfer to neurons and glia: Analysis of adenoviral vector performance in the CNS and PNS. J. Neurosci. Methods 71: 85-98.
23. Hermens, W. T. J. M. C., W. H. Gispen, and J. Verhaagen. 1996. Prolonged Gene Expression in Glial Cells but Not Neurons with Recombinant Adenoviruses in the Facial Nucleus of Athymic nu/nu Rats. Annual Meeting of the American Society of Neuroscience, Washington, DC, [abstract 130.11].
24. Horellou, P., E. Vigne, M.-N. Castel, P. Barnéou, P. Colin, M. Perricaudet, P. Delaère, and J. Mallet. 1994. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's Disease. Neuroreport 6: 49-53.
25. Kordower, J. H., M. S. Fiandaca, M. F. D. Notter, J. T. Hansen, and D. M. Gash. 1990. NGF-like trophic support from peripheral nerve for grafted rhesus adrenal dhromaffin cells. J. Neurosurg. 73: 418-428.
26. Le Gal La Salle, G., J. J. Robert, S. Berrard, V. Ridoux, L. D. Stratford-Perricaudet, M. Perricaudet, and J. Mallet. 1993. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259: 988-990.
27. Lehman, M. N., R. Silver, W. R. Gladstone, R. M. Kahn, M. Gibson, and E. L. Bittman. 1987. Circadian rhythmicity restored by neural transplant. Immunocytochemical characterization of the graft and its integration with the host brain. J. Neurosci. 7: 1626-1638.
28. Lehman, M. N., H. T. Jansen, M. Wortman, P. Stevens, C. Kim, R. B. Norgren, and P. Zeitler. 1996. Neurotrophin and Neurotrophin Receptor Expression in the Suprachiasmatic Nucleus (SCN) of Rats and Hamsters. Am. Neurosci. Meeting, Washington, DC, [abstract 451.11].
29. Levivier, M., S. Przedborski, C. Bencsics, and U. Jung Kang. 1995. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 15: 7810-7820.
30. Liang, F-O., R. Miranda, F. Sohrabji, C. Brooks, and D. Earnest. 1996. Brain-Derived Neurotrophic Factor and TrkB Receptors in the Rat SCN: Distribution and Functional Implications. Am. Neurosci. Meeting, Washington, DC, [abstract 451.12].
31. Olson, L. 1993. Reparative strategies in the brain: treatment strategies based on trophic factors and cell transfer techniques. Acta Neurochir. 58: 3-7.
32. Palmer, T. D., G. J. Rosman, W. R. A. Osborne, and A. D. Miller. 1991. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88: 1330-1334.
33. Ridoux, V., J. J. Robert, X. Zhang, M. Perricaudet, J. Mallet, and G. Le Gal La Salle. 1994. The use of adenovirus vectors for intracerebral grafting of transfected nervous cells. Neuroreport 5: 801-804.
34. Romijn, H. J., B. M. De Jong, and J. M. Ruijter. 1988. A procedure for culturing rat neocortex explants in a serum-free nutrient medium. J. Neurosci. Methods 23: 75-83.
35. Rosenberg, M. B., T. Friedmann, R. C. Robertson, M. Tuszynski, J. A. Wolff, X. O. Breakefield, and F. H. Gage. 1988. Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science 242: 1575-1578.
36. Rosenstein, J. M., and N. S. More. 1994. Immunocytochemical expression of the blood-brain barrier glucose transporter (GLUT-1) in neural transplants and brain wounds. J. Comp. Neurol. 350: 229-240.
37. Sabaté, O., P. Horellou, E. Vigne, P. Colin, M. Perricaudet, M.-H. Buc-Caron, and J. Mallet. 1995. Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nature Genet. 9: 256-260.
38. Silver, R., J. Lesauter, P. A. Tresco, and M. N. Lehman. 1996. A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature 382: 810-813.
39. Sofroniew, M. V., O. Isacson, and T. S. O'Brien. 1989. Nerve growth factor receptor immunoreactivity in the rat suprachiasmatic nucleus. Brain Res. 476: 358-362.
40. Sterio, D. C. 1984. The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc. 134: 127-136.
41. Strömberg, I., C. J. Wetmore, T. Ebendal, P. Ernfors, H. Persson, and L. Olson. 1990. Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J. Neurosc. Res. 25: 405-411.
42. Van Esseveldt, K. E., W. T. J. M. C. Hermens, R. Liu, R. W. H. Verwer, J. Verhaagen, and G. J. Boer. 1996. Ex Vivo Adenovirus-Mediated Gene Transfer into Suprachiasmatic Nucleus (SCN) Transplant. Annual Meeting of the American Society of Neuroscience, Washington, DC, [abstract 306.10].
43. Van Esseveldt, K. E., R. Liu, W. T. J. M. C. Hermens, J. Verhaagen, and G. J. Boer. 1997. Adenoviral vector-mediated gene transfer and neurotransplantation: Possibilities and limitations in grafting of the suprachiasmatic nucleus. J. Neurosci. Methods 71: 113-123
44. Wiestler, O. D., A. Aguzzi, M. Schneemann, R. Eibl, A. von Deimling, and P. Keihues. 1992. Oncogene complementation in fetal brain transplants. Cancer Res. 52: 3760-3767.
45. Wiestler, O. D., O. Brüstle, R. H. Eibl, H. Radner, A. Aguzzi, and P. Kleihues. 1994. Oncogene transfer to the brain: Recent results. Cancer Res. 135: 55-66.
46. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gönczöl, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91: 4407-4411.